Under normal physiological conditions, ICAM-1 is expressed at low levels on endothelial cells, fibroblasts, and epithelial cells. However, its expression is markedly upregulated in response to pro-inflammatory cytokines like TNF-α (Tumor Necrosis Factor-alpha) and IL-1 (Interleukin-1), as well as other inflammatory stimuli.